Study on the Effects of Rifaximin on Stress and Fear Responses in Healthy Men
- Substances:Rifaximin
Belgium- Participants:18–64 years · Healthy volunteers
- Substances:Rifaximin
- Sponsor:UZ Leuven
Rare diseases
Investigational molecules
Locations
Back to Belgium1 831 clinical trials in Sint-Truiden, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.
BelgiumStudy on the Effects of Naloxegol and Codeine on Opioid-Induced Constipation in Healthy Volunteers
BelgiumStudy on the Effectiveness of Durvalumab and BCG in Treating High-Risk, Non-Muscle Invasive Bladder Cancer in Patients New to BCG Treatment
BelgiumStudy on COVID-19 Prevention Using Sipavibart and Cilgavimab for Patients with Weakened Immune Systems
BelgiumStudy on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers
BelgiumStudy on the 9vHPV Vaccine for Preventing Oral HPV Infections in Men Aged 20-45
BelgiumStudy on the Effects of Liraglutide on Hunger and Digestion in Obese Patients
BelgiumStudy on the Safety and Effectiveness of Volrustomig with FOLFIRI and Bevacizumab for Colorectal Cancer Patients Without Liver Metastases
FranceStudy on How Apixaban and Teduglutide Affect Patients with Short Bowel Syndrome on Long-Term Parenteral Nutrition
BelgiumStudy of intranasal lysine-aspirin effectiveness in patients with NSAID-exacerbated respiratory disease (N-ERD)
BelgiumStudy Comparing Axatilimab to Best Available Therapy for Patients with Chronic Graft-Versus-Host Disease After Two or More Treatments
BelgiumStudy of BT8009 for Patients with Advanced Breast Cancer with NECTIN4 Amplification
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials focusing on colon cancer treatment and survival outcomes. The research explores innovative approaches to prevent cancer recurrence in patients who have undergone surgical treatment.
This research investigates the potential benefits of common acetylsalicylic acid in improving survival rates for patients with stage II and III colon cancer, representing a significant advancement in post-operative cancer care protocols.
Innovative research examining the role of daily preventive therapy in cancer management. The study focuses on long-term treatment strategies spanning five years to enhance patient outcomes.
This comprehensive trial evaluates the effectiveness of low-dose medication regimens in preventing cancer recurrence, potentially establishing new standards in preventive oncology.
Advanced research targeting patients with resected colon carcinoma, exploring post-surgical intervention strategies to improve long-term patient outcomes.
The study aims to establish effective post-surgical treatment protocols, potentially transforming the standard of care for colon cancer patients following tumor resection.
Tell us about your condition – we search every trial in Europe and connect you with the right site.